Milestone Pharmaceuticals (MIST) Change in Accured Expenses (2018 - 2026)

Milestone Pharmaceuticals (MIST) has 9 years of Change in Accured Expenses data on file, last reported at $1.8 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 58.41% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 78.74% YoY) and the FY2025 annual result came in at $4.4 million, up 406.51% from the prior year.
• Change in Accured Expenses eased to $1.8 million in Q1 2026, from $1.9 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $4.4 million in Q1 2025 to a low of -$3.4 million in Q1 2024.
• A 5-year average of $427764.7 and a median of $676000.0 in 2024 frame the typical range for Change in Accured Expenses.
• The widest YoY moves for Change in Accured Expenses: up 418.47% in 2024, down 10500.0% in 2024.
• Tracing MIST's Change in Accured Expenses over 5 years: stood at -$391000.0 in 2022, then slumped by 131.2% to -$904000.0 in 2023, then jumped by 418.47% to $2.9 million in 2024, then tumbled by 32.41% to $1.9 million in 2025, then declined by 5.65% to $1.8 million in 2026.
• The last three Change in Accured Expenses figures came in at $1.8 million (Q1 2026), $1.9 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.